Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1999
02/04/1999WO1999005136A1 Macrocyclic lactones, compositions, and methods of use
02/04/1999WO1999005135A1 Polyophenol compounds and drugs containing the same
02/04/1999WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
02/04/1999WO1999005132A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
02/04/1999WO1999005131A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
02/04/1999WO1999005123A1 Novel pyrimidin derivatives
02/04/1999WO1999005121A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
02/04/1999WO1999005117A1 Hydantoin derivatives having an inhibitory activity for farnesyl transferase
02/04/1999WO1999005113A1 Substituted 6-phenylphenanthridines
02/04/1999WO1999005112A1 Substituted 6-alkylphenanthridines
02/04/1999WO1999005111A1 Novel tetrazole derivatives
02/04/1999WO1999005107A1 Vitronectin receptor antagonist
02/04/1999WO1999005105A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
02/04/1999WO1999005104A1 Indole compounds as cox-2 inhibitors
02/04/1999WO1999005103A2 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
02/04/1999WO1999005096A2 Urokinase inhibitors
02/04/1999WO1999005095A1 Aminocycloalkane compounds
02/04/1999WO1999005091A1 Novel compound having effect of promoting neuron differentiation
02/04/1999WO1999005090A1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
02/04/1999WO1999004824A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents
02/04/1999WO1999004823A1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
02/04/1999WO1999004822A2 New salts with beneficial organoleptic properties
02/04/1999WO1999004821A2 Immobilization of vitamin a acid by cationic polyelectrolytes
02/04/1999WO1999004819A1 Liposomal compositions for the delivery of nucleic acid catalysts
02/04/1999WO1999004817A1 Chemotherapy synergistic agent
02/04/1999WO1999004816A1 Proton pump inhibitor in therapeutic combination with antibacterial substances
02/04/1999WO1999004815A1 Medicinal compositions with cholesterol-lowering effect
02/04/1999WO1999004804A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body
02/04/1999WO1999004801A1 Use of sulfated glycosaminoglycans for treating of retinopathy
02/04/1999WO1999004799A1 Fatty emulsions containing reducing sugar and method for sterilizing the same
02/04/1999WO1999004798A1 Lyophilized fosphenytoin sodium for parenteral use
02/04/1999WO1999004797A1 Use of 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions to treat diseases connected with the endogenous opioid system
02/04/1999WO1999004796A1 Fibrinogen receptor antagonists
02/04/1999WO1999004795A1 Delta opioid receptor agonist for reducing ischemic damage
02/04/1999WO1999004794A1 Cyclic amine modulators of chemokine receptor activity
02/04/1999WO1999004793A2 Budipine in the treatment of inflammatory disorders of the nervous system
02/04/1999WO1999004792A1 Novel azatyrosine analogues and process of preparation thereof
02/04/1999WO1999004791A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999WO1999004790A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
02/04/1999WO1999004789A1 Substituted aurone derivatives
02/04/1999WO1999004788A1 Aqueous compositions comprising ranitidine and lcmt sucrose
02/04/1999WO1999004787A1 Taxol emulsion
02/04/1999WO1999004786A1 Inhibitor and therapeutic agent for brain aging
02/04/1999WO1999004785A1 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
02/04/1999WO1999004783A1 Composition for protection from damage by ischemia
02/04/1999WO1999004782A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
02/04/1999WO1999004781A1 Protecting and survival promoting agent for central nervous cell
02/04/1999WO1999004780A1 Therapeutic or prophylactic agent for glomerulopathy
02/04/1999WO1999004779A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin
02/04/1999WO1999004778A1 Pharmaceutical compounds
02/04/1999WO1999004777A1 Carcinostatics
02/04/1999WO1999004776A1 Antitumor agents
02/04/1999WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders
02/04/1999WO1999004774A2 Nucleotide analog compositions
02/04/1999WO1999004773A2 Method for inhibiting bone resorption
02/04/1999WO1999004772A2 Use of levobupivacaine
02/04/1999WO1999004771A2 Use of levobupivacaine
02/04/1999WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999WO1999004769A2 Use of aminoacridines for the treatment of solid tumours, metastases and lymphomas
02/04/1999WO1999004766A1 Method for preparing vesicular nanocapsules
02/04/1999WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple
02/04/1999WO1999004764A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity
02/04/1999WO1999004763A1 Improved multiparticulate tablet with quick disintegration
02/04/1999WO1999004761A1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
02/04/1999WO1999004628A1 Phototherapy based method for treating pathogens and composition for effecting same
02/04/1999WO1998051663A3 3-epi compounds of vitamin d3 and uses thereof
02/04/1999WO1998050424A3 Human serine protease precursor
02/04/1999WO1998050419A3 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase
02/04/1999WO1998050016A3 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
02/04/1999DE19733505A1 Schnell wirksames Analgeticum Fast-acting analgesic
02/04/1999DE19733439A1 Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften New 6-endo-amino-3-azabicyclo (3.1.0) hexande, processes for their preparation and their use for the preparation of quinolone and naphthyridine-Derviaten with improved properties
02/04/1999DE19733094A1 Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität Formulation based on ascorbic acid with improved color stability
02/04/1999DE19732903A1 Pellet-Formulierung zur Behandlung des Intestinaltraktes The pellet formulation for the treatment of the intestinal tract
02/04/1999DE19731432A1 Use of choline citrate to treat CNS disorders
02/04/1999CA2349744A1 Inhibition bone resorption
02/04/1999CA2349733A1 Inhibition bone resorption
02/04/1999CA2301166A1 Liposomal compositions for the delivery of nucleic acid catalysts
02/04/1999CA2298795A1 Agent for protecting central nerve cells and enhancing survival thereof
02/04/1999CA2298526A1 Phototherapy based method for treating pathogens and composition for effecting same
02/04/1999CA2298507A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999CA2298067A1 Conjugates of transporter peptides and nucleic acid analogs, and their use
02/04/1999CA2298065A1 Immobilization of vitamin a acid by cationic polyelectrolytes
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2297943A1 Novel compound having effect of promoting neuron differentiation
02/04/1999CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors
02/04/1999CA2297910A1 Vitronectin receptor antagonist
02/04/1999CA2297909A1 Fibrinogen receptor antagonists
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2297906A1 Pharmaceutical compounds
02/04/1999CA2297760A1 Method for preparing vesicular nanocapsules
02/04/1999CA2297753A1 Substituted aurone derivatives
02/04/1999CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
02/04/1999CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders
02/04/1999CA2297315A1 Endothelin receptor antagonists
02/04/1999CA2297251A1 Delta opioid receptor agonist for reducing ischemic damage
02/04/1999CA2297183A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body
02/04/1999CA2297166A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
02/04/1999CA2297025A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents
02/04/1999CA2296654A1 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity
02/04/1999CA2296648A1 Novel compounds
1 ... 6543 6544 6545 6546 6547 6548 6549 6550 6551 6552 6553 6554 6555 6556 6557 6558 6559 6560 6561 6562 6563 ... 7860